ArticleInternational urogynecology journal2025
Long-Term Outcomes of Transvaginal Sacrospinous Ligament Suture Rectopexy.
Article in International urogynecology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introduction and hypothesisObstructed defecation syndrome (ODS) is characterized by a combination of straining, incomplete evacuation, and the use of digital manipulation with defecation. Transvaginal sacrospinous ligament suture rectopexy has been shown to effectively improve obstructed defecation symptoms caused by rectal partial prolapse and lack of support during first year postoperatively. This study aimed to investigate the long-term clinical and anatomical outcomes of this novel and minimally invasive surgery. MATERIALS AND
methodsThis longitudinal prospective cohort study was performed at a tertiary, university-affiliated pelvic health clinic. Women who underwent transvaginal sacrospinous rectopexy for treatment of ODS and for whom time since their surgery was at least 12 months were eligible for inclusion. Patients were contacted via telephone and were offered to come for an in-person evaluation, including symptom assessment (ODS symptoms, PFDI-20 and PGI-I questionnaires), POP-Q evaluation, and 3D dynamic ultrasound for assessment of rectal hypermobility. Clinical success was defined as not having any ODS symptoms (straining, incomplete emptying, or need to splint) in over 50% of bowel movements. Anatomical success was defined as not having rectal prolapse and compression ratio on ultrasound assessment of less than 50%.
resultsA total of 135 patients were eligible for inclusion, out of which 65 patients, averaging 63.3 ± 13.3 years in age and 27.1 ± 5.6 in body mass index (BMI), were recruited. Median follow-up time was 29 months. Subjective failure was noted in 18 patients (28.1%) who experienced symptoms in more than 50% of bowel movements. Anatomical failure, defined as having a compression ratio of more than 50% or rectal prolapse, was noted in seven patients (12.7%). Three patients failed treatment with a recurrence of rectal prolapse and two patients underwent ventral mesh rectopexy within 1 year after surgery. Ultrasound measurements revealed that compression ratio significantly reduced from 52.9% ± 24.7 to 17.7% ± 12.3 (p < 0.001), indicating substantial anatomical improvements during the follow-up period.
conclusionIn conclusion, this study indicates that transvaginal sacrospinous ligament rectopexy is a safe, feasible, and minimally invasive effective alternative for treating ODS.
Indexed as
Identifiers
40042604What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.